Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1984 1
1986 1
1993 1
1994 1
1996 1
1997 1
1998 1
1999 1
2000 4
2001 1
2003 2
2004 3
2005 1
2006 3
2007 3
2008 1
2009 3
2010 3
2011 4
2012 8
2013 4
2014 4
2015 3
2016 1
2019 1
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
[Pituitary metastases: a diagnostic and therapeutic challenge].
Loto MG, Rogozinski A, Alfieri A, Ballarino MC, Battistone MF, Chervin A, Danilowicz KD, Diez S, Fainstein Day P, Furioso A, Glerean M, Gonzalez Pernas M, Katz D, Mallea Gil MS, Martinez M, Miragaya KA, Sabate MI, Slavinsky P, Sosa S, Szuman G, Tkatch J, Vitale MN, Guitelman M. Loto MG, et al. Among authors: chervin a. Medicina (B Aires). 2024;84(3):505-515. Medicina (B Aires). 2024. PMID: 38907965 Free article. Spanish.
A 12-month phase 3 study of pasireotide in Cushing's disease.
Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM; Pasireotide B2305 Study Group. Colao A, et al. N Engl J Med. 2012 Mar 8;366(10):914-24. doi: 10.1056/NEJMoa1105743. N Engl J Med. 2012. PMID: 22397653 Free article. Clinical Trial.
Primary empty sella (PES): a review of 175 cases.
Guitelman M, Garcia Basavilbaso N, Vitale M, Chervin A, Katz D, Miragaya K, Herrera J, Cornalo D, Servidio M, Boero L, Manavela M, Danilowicz K, Alfieri A, Stalldecker G, Glerean M, Fainstein Day P, Ballarino C, Mallea Gil MS, Rogozinski A. Guitelman M, et al. Among authors: chervin a. Pituitary. 2013 Jun;16(2):270-4. doi: 10.1007/s11102-012-0416-6. Pituitary. 2013. PMID: 22875743 Review.
Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma.
Dandamudi DB, Konieczna IM, Calabrese KM, Wielgos-Bonvallet M, Kweekel C, Gresnigt-van den Heuvel E, Iyer R, Ellis P, Rodriguez L, Parikh A, Li T, Paauwe M, Cosgrove C, Chervin AS, Reilly EB, Epling-Burnette P, Szafer-Glusman E. Dandamudi DB, et al. Among authors: chervin as. Leuk Lymphoma. 2025 Sep;66(9):1688-1699. doi: 10.1080/10428194.2025.2504719. Epub 2025 Jun 18. Leuk Lymphoma. 2025. PMID: 40528731 Free article.
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.
Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M; Pasireotide C2305 Study Group. Colao A, et al. J Clin Endocrinol Metab. 2014 Mar;99(3):791-9. doi: 10.1210/jc.2013-2480. Epub 2014 Jan 13. J Clin Endocrinol Metab. 2014. PMID: 24423324 Free PMC article. Clinical Trial.
Pegvisomant in acromegaly: a multicenter real-life study in Argentina.
Basavilbaso NXG, Ballarino MC, Bruera D, Bruno OD, Chervin AB, Danilowicz K, Fainstein-Day P, Fidalgo SG, Frigeri A, Glerean M, Guelman R, Isaac G, Katz DA, Knoblovits P, Librandi F, Montes ML, Mallea-Gil MS, Manavela M, Mereshian P, Moncet D, Pignatta A, Rogozinsky A, Sago LR, Servidio M, Spezzi M, Stalldecker G, Tkatch J, Vitale NM, Guitelman M. Basavilbaso NXG, et al. Among authors: chervin ab. Arch Endocrinol Metab. 2019 Aug 22;63(4):320-327. doi: 10.20945/2359-3997000000160. Arch Endocrinol Metab. 2019. PMID: 31460622 Free PMC article.
55 results